HomeBusinessAfter the demerger, Piramal Pharma reports a loss for the second quarter.

After the demerger, Piramal Pharma reports a loss for the second quarter.

Business

Published on

By lapaasindia
spot_img
  • In contrast to the same period last year, Piramal Pharma recorded a net loss of Rs 37 crore for the second quarter that ended in September on Wednesday.
  • However, the company’s operating revenue increased to Rs 1,720 crore during the quarter of July through September from Rs 1,578 crore in the equivalent quarter of the previous fiscal.

Latest articles

Business

Zepto claims 2nd spot in monthly active customers, surpasses JioMart

Zepto, a Bengaluru-based quick-commerce app, has surged ahead of JioMart in November, securing the...
Business

Google unveils long-awaited Gemini AI model to Catch Up to OpenAI

Google released its advanced chatbot, Bard, underpinned by the new A.I. technology, Gemini, as...
Business

Domestic electronics manufacturing up 4x to Rs 8.22 lakh cr in FY23 : IT Ministry

Over the last decade, domestic electronics manufacturing in India has witnessed remarkable growth, increasing...
Startup

MPL post Rs 814 crore revenue & around Rs 300 crore loss in FY23

The Indian entity of MPL reported Rs 814.2 crore in revenue from operations in...

More like this

Business

Zepto claims 2nd spot in monthly active customers, surpasses JioMart

Zepto, a Bengaluru-based quick-commerce app, has surged ahead of JioMart in November, securing the...
Business

Google unveils long-awaited Gemini AI model to Catch Up to OpenAI

Google released its advanced chatbot, Bard, underpinned by the new A.I. technology, Gemini, as...
Business

Domestic electronics manufacturing up 4x to Rs 8.22 lakh cr in FY23 : IT Ministry

Over the last decade, domestic electronics manufacturing in India has witnessed remarkable growth, increasing...

We help you to learn,understand and update all the current affairs related to the business and startup world.

© Lapaas Voice